Soligenix's IPO

Soligenix raised a round of funding on October 06, 2003. Investors include Public.

Soligenix is a clinical stage biopharmaceutical company developing products to treat serious gastrointestinal diseases where there remains an unmet medical need, as well as developing several biodefen…

Articles about Soligenix's IPO: